Medicines management in 2020 brings together representatives of German regulatory authorities, health insurance and health technology assessment as well the industry's top executives to explore the lasts changes in German drug policy and the latest trends from biosimilars to digitisation in health care.
Ask for a Free trial and get access to our last stories
- Health Care
- Market Access
- HTA – policies & practices
- European medicine regulations
- Drug safety issues
- Pricing & Reimbursement
- International medicines agencies
If you are a Payer, Pharmaceutical or Consulting professional our premium data will keep you informed on the regulatory, pricing, market access and cost-effectiveness issues that impact all stakeholders.
an initial 10 day temporary access of APM Health Europe.